The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER (FOVUS-ER)
Primary Purpose
Chest Pain, Acute Coronary Syndrome, Carotid Artery Plaque
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Focused vascular ultrasound of the carotid arteries
Sponsored by
About this trial
This is an interventional diagnostic trial for Chest Pain
Eligibility Criteria
Inclusion Criteria:
- Men and women ≥25 years of age;
- Chief complaint of chest pain possibly due to coronary ischemia and requiring cardiac investigations (e.g. ECG, troponin) in the opinion of the treating emergency physician;
- Receiving at least one 12-lead ECG;
- Receiving at least one serum troponin measurement;
- Willing to provide informed consent.
Exclusion Criteria:
- Acute ST-segment elevation on the initial ECG;
- Hemodynamic instability;
- High clinical suspicion of pulmonary edema;
- History of recent cocaine or amphetamine use;
- Inability to communicate in English;
- A clear traumatic etiology;
- Prior enrollment in the study within the past 6 months;
- Terminal non-cardiac illness;
- Previous carotid surgery (endarterectomy or stent);
- Anatomic consideration rendering carotid artery inaccessible (tumor, abscess, scarring, mechanical device).
Sites / Locations
- Queen's University
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
FOVUS
Arm Description
All eligible and consenting patients will receive a focused vascular ultrasound examination of the carotid arteries
Outcomes
Primary Outcome Measures
Major adverse cardiac events
Major adverse cardiac events will include acute myocardial infarction (MI),revascularization or mortality
Secondary Outcome Measures
Plaque height measurement during FOVUS
Agreement between ultrasonographers and emergency physicians with respect to plaque height measurement will be calculated using this outcome
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02947360
Brief Title
The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER
Acronym
FOVUS-ER
Official Title
The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Suspected Ischemic Chest Pain in the Emergency Department
Study Type
Interventional
2. Study Status
Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
November 2016 (Actual)
Primary Completion Date
December 17, 2018 (Actual)
Study Completion Date
December 17, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Queen's University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Broad Goal: To demonstrate that focused vascular ultrasound (FOVUS) can accurately risk stratify patients with chest pain in the emergency department (ED).
Background and Rationale: Traditional risk assessment focuses on characteristics of the pain, known Coronary Artery Disease (CAD), risk factors, electrocardiogram (ECG), and blood tests to identify active ischemia. Identifying clinically significant CAD remains one of the most challenging tasks in the ED. Current clinical decision rules err on the side of over investigation and admission. To address this limitation, the Investigators have developed a point-of-care carotid ultrasound test predictive of CAD. The Investigators have shown that carotid plaque is strongly associated with significant angiographic CAD in a population referred for angiogram.
Research Aims:
Primary - To determine the association between carotid plaque measured by a dedicated sonographer and 30-day major adverse cardiac events (MACE), including MI, reperfusion, or death in patients presenting to the ED with suspected cardiac ischemia.
Secondary - To determine the agreement sonographer and emergency physician FOVUS results.
Methodology: The Investigators propose a prospective cohort study to assess the prognostic value of a novel point-of-care carotid ultrasound plaque quantification protocol in the ED of Kingston General Hospital. We will enroll 500 consecutive patients presenting with a chief complaint of chest pain prompting at least one 12-lead ECG and troponin measurement. Patients will undergo carotid scan by a dedicated sonographer and emergency physician. Patients will be followed for MACE for 30 days. Those performing scans will be blinded to clinician's impression and care plans while clinicians will be blinded to FOVUS findings. The primary analysis will involve determination of the sensitivity, sensitivity, positive predictive value, negative predictive value and likelihood ratios associated with FOVUS for 30-day MACE.
Expected Outcomes: The study will provide evidence to determine whether FOVUS may be a useful prognostic tool for emergency physicians assessing patients with suspected ischemic chest pain. The secondary analysis will provide evidence to determine whether emergency physicians can be trained to measure carotid plaque height accurately when compared to the gold standard ultrasonographer measurement.
Significance: If FOVUS can reliably identify very low risk patients, implementation of this novel tool could reduce ED length of stay, monitoring, and overcrowding.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chest Pain, Acute Coronary Syndrome, Carotid Artery Plaque
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
326 (Actual)
8. Arms, Groups, and Interventions
Arm Title
FOVUS
Arm Type
Experimental
Arm Description
All eligible and consenting patients will receive a focused vascular ultrasound examination of the carotid arteries
Intervention Type
Other
Intervention Name(s)
Focused vascular ultrasound of the carotid arteries
Other Intervention Name(s)
FOVUS
Intervention Description
Emergency physicians and a trained research sonographer will perform a focused vascular ultrasound of the carotids (FOVUS) in patients presenting to the emergency department with chest pain. The diagnostic test characteristics (sensitivity, sensitivity, negative predictive value, positive predictive value and likelihood ratios) for FOVUS carotid plaque height will be determined in relation to our primary outcome (30-day major adverse cardiac events)
Primary Outcome Measure Information:
Title
Major adverse cardiac events
Description
Major adverse cardiac events will include acute myocardial infarction (MI),revascularization or mortality
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Plaque height measurement during FOVUS
Description
Agreement between ultrasonographers and emergency physicians with respect to plaque height measurement will be calculated using this outcome
Time Frame
At enrollment
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Men and women ≥25 years of age;
Chief complaint of chest pain possibly due to coronary ischemia and requiring cardiac investigations (e.g. ECG, troponin) in the opinion of the treating emergency physician;
Receiving at least one 12-lead ECG;
Receiving at least one serum troponin measurement;
Willing to provide informed consent.
Exclusion Criteria:
Acute ST-segment elevation on the initial ECG;
Hemodynamic instability;
High clinical suspicion of pulmonary edema;
History of recent cocaine or amphetamine use;
Inability to communicate in English;
A clear traumatic etiology;
Prior enrollment in the study within the past 6 months;
Terminal non-cardiac illness;
Previous carotid surgery (endarterectomy or stent);
Anatomic consideration rendering carotid artery inaccessible (tumor, abscess, scarring, mechanical device).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven C Brooks, MD, MHSc
Organizational Affiliation
Queen's University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Queen's University
City
Kingston
State/Province
Ontario
ZIP/Postal Code
K7L 2V7
Country
Canada
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
36315347
Citation
Brooks SC, Sivilotti MLA, Hetu MF, Norman PA, Day AG, O'Callaghan N, Latiu V, Newbigging J, Hill B, Johri AM. Focused carotid ultrasound to predict major adverse cardiac events among emergency department patients with chest pain. CJEM. 2023 Jan;25(1):81-89. doi: 10.1007/s43678-022-00395-w. Epub 2022 Oct 31.
Results Reference
derived
Learn more about this trial
The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER
We'll reach out to this number within 24 hrs